Effects of Continuous Intravenous Infusion of Dexmedetomidine Combined with Oxycodone on Inflammatory Response and Immune Function in Patients with Breast Cancer During General Anesthesia

NING Lijuan; LIU Xiaomei

doi:10.14009/j.issn.1672-2124.2022.12.004

您当前的位置：

首页 >

文章列表页 >

Effects of Continuous Intravenous Infusion of Dexmedetomidine Combined with Oxycodone on Inflammatory Response and Immune Function in Patients with Breast Cancer During General Anesthesia

更新时间：2023-04-16

- Effects of Continuous Intravenous Infusion of Dexmedetomidine Combined with Oxycodone on Inflammatory Response and Immune Function in Patients with Breast Cancer During General Anesthesia
- Issue 12, Pages: 1447-1450(2022)
- 作者机构：
  
  中国人民解放军总医院第六医学中心麻醉科
- 作者简介：
- 基金信息：
- DOI：10.14009/j.issn.1672-2124.2022.12.004
  CLC： R737.9;R614.2
- Published：2022，
扫描看全文
NING Lijuan, LIU Xiaomei. Effects of Continuous Intravenous Infusion of Dexmedetomidine Combined with Oxycodone on Inflammatory Response and Immune Function in Patients with Breast Cancer During General Anesthesia. [J]. (12):1447-1450(2022)
DOI：

NING Lijuan, LIU Xiaomei. Effects of Continuous Intravenous Infusion of Dexmedetomidine Combined with Oxycodone on Inflammatory Response and Immune Function in Patients with Breast Cancer During General Anesthesia. [J]. (12):1447-1450(2022) DOI： 10.14009/j.issn.1672-2124.2022.12.004.

摘要

目的：探讨长期静脉输注右美托咪定联合羟考酮对乳腺癌患者术后炎症反应和免疫功能的影响。方法：选取该院于2020年1月至2021年1月收治的乳腺癌患者共87例，根据随机数字表法分为观察组（43例）和对照组（44例）。对照组患者全身麻醉过程中给予羟考酮持续输注，观察组患者在对照组的基础上给予右美托咪定持续输注。记录两组患者术前的一般状况（包括年龄、病程、体重和血清白蛋白水平）

治疗前后的免疫功能[单核细胞人白血病抗原-DR（mHLA-DR）、可溶性上皮型钙黏蛋白（sE-cad）]、炎症反应[肿瘤坏死因子（TNF-α）、白细胞介素（IL）6]和视觉模拟评分（VAS）

观察不良反应。结果：术毕、术后1 d和术后3 d

两组患者mHLA-DR水平均较治疗前显著升高，sE-cad水平显著降低；且观察组患者mHLA-DR水平显著高于同期对照组，sE-cad水平显著低于同期对照组，差异均有统计学意义（P＜0.05）。术毕、术后1 d和术后3 d

观察组患者TNF-α含量显著低于同期对照组，差异均有统计学意义（P＜0.05）。两组患者术后6、12 h的VAS评分与术后1 h相比显著降低；观察组患者术后1、6和12 h的VAS评分显著低于对照组，差异均有统计学意义（P＜0.05）。两组患者未见严重不可逆的不良反应，不良反应发生率的差异无统计学意义（P＞0.05）。结论：持续静脉输注右美托咪定联合羟考酮能有效减轻乳腺癌患者术后炎症反应，改善患者术后免疫功能，减轻术后疼痛程度。

Abstract

OBJECTIVE: To explore the effects of long-term intravenous infusion of dexmedetomidine combined with oxycodone on postoperative inflammatory response and immune function in patients with breast cancer. METHODS: A total of 87 patients with breast cancer admitted to the hospital from Jan. 2020 to Jan. 2021 were selected and randomly divided into observation group（43 cases） and control group（44 cases）. Patients in the control group were given continuous infusion of oxycodone during general anesthesia

and patients in the observation group were given continuous infusion of dexmedetomidine on the basis of patients in the control group.The general conditions of patients in 2 groups before operation（including age

course of disease

weight

the level of serum albumin）

immune function（including mHLA-DR

sE-cad）

inflammatory response（including TNF-α

IL-6） and visual analogue scale（VAS） before and after treatment

and adverse reactions were recorded. RESULTS: Compared with before operation

the levels of mHLA-DR in two groups were increased significantly

while the levels of sE-cad were decreased significantly at the end of operation

1 day and 3 days after operation; the level of mHLA-DR in observation group was significantly higher than control group

while the level of sE-cad was significantly lower than control group at the same period

with statistical significance（P<0.05）. At the end of operation

1 day and 3 days after operation

the content of TNF-α in observation group was significantly lower than control group

with statistical significance（P<0.05）. VAS scores of 2 groups 6 and 12 h after operation were significantly decreased compared with 1 h after operation; VAS scores of observation groups were significantly lower than that of control group

with statistical significance（P<0.05）. There was no serious irreversible adverse reaction in two groups

and there was no significant difference in the incidence of adverse drug reactions（P>0.05）. CONCLUSIONS: Continuous intravenous infusion of dexmedetomidine combined with oxycodone can effectively reduce postoperative inflammatory response

improve postoperative immune function and reduce postoperative pain in patients with breast cancer.

关键词

羟考酮右美托咪定乳腺癌免疫应激炎症反应

Keywords

OxycodoneDexmedetomidineBreast cancerImmune stressInflammatory response

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Efficacy of Liangxue Huoxue Recipe Application in the Treatment of Acute Gouty Arthritis of Dampness-Heat Accumulation Type and Its Effect on Th17/Treg Cell Balance

Efficacy of Internal Iliac Artery Transcatheter Arterial Chemoembolization with Gemcitabine Combined with Cisplatin/Lobaplatin in the Treatment of Muscle Invasive Bladder Urothelial Carcinoma

Effects of Fiberoptic Bronchoalveolar Lavage Combined with Azithromycin on Immune Function, Serum MCP-4, MAPK and CysLTR1 in Children with Mycoplasma Pneumoniae Pneumonia

Comparative Study on Different Administration Method of Propofol in Breast Cancer Surgery

Effects of Danshen Ligustrazine Injection Combined with EC-T Regimen on Short-Term Efficacy, Immune Function and Quality of Life in Patients with Breast Cancer After Surgery

Related Author

LI Qian

DI Shengxia

ZHANG Yitong

ZHANG Jun

LIANG Hui

DING Jin

ZENG Jianyong

LIU Ying

Related Institution

Dept.of Radiology, Shijiazhuang Traditional Chinese Medicine Hospital

Dept.of Orthopedics, Shijiazhuang Traditional Chinese Medicine Hospital

Dept. of Urology, Chengdu Sixth People’s Hospital

Dept. of Pharmacy, Chengdu Sixth People’s Hospital

Pediatric Intensive Care Unit, Chengdu Women’s and Children’s Central Hospital

⁰